Equillium, Inc. (EQ)
2.27
-0.12
(-5.02%)
USD |
NASDAQ |
Aug 31, 16:00
2.265
0.00 (0.00%)
After-Hours: 20:00
Equillium Cash from Operations (Annual) : -22.75M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -22.75M |
| December 31, 2024 | -19.03M |
| December 31, 2023 | -21.78M |
| December 31, 2022 | -8.733M |
| December 31, 2021 | -32.08M |
| Date | Value |
|---|---|
| December 31, 2020 | -24.62M |
| December 31, 2019 | -22.95M |
| December 31, 2018 | -7.526M |
| December 31, 2017 | -0.6622M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Fortress Biotech, Inc. | -71.34M |
| Cue Biopharma, Inc. | -21.69M |
| Legend Biotech Corp. | -100.46M |
| Dianthus Therapeutics, Inc. | -129.06M |